Free Trial

Harmony Biosciences (HRMY) Short Interest Ratio & Short Volume

Harmony Biosciences logo
$32.79 +0.31 (+0.95%)
(As of 11/20/2024 ET)

Harmony Biosciences Short Interest Data

Harmony Biosciences (HRMY) has a short interest of 6.06 million shares, representing 15.15% of the float (the number of shares available for trading by the public). This marks a -18.66% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.9, indicating that it would take 8.9 days of the average trading volume of 1.24 million shares to cover all short positions.

Current Short Interest
6,060,000 shares
Previous Short Interest
7,450,000 shares
Change Vs. Previous Month
-18.66%
Dollar Volume Sold Short
$194.71 million
Short Interest Ratio
8.9 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
57,030,000 shares
Float Size
40,010,000 shares
Short Percent of Float
15.15%
Today's Trading Volume
311,020 shares
Average Trading Volume
1,242,829 shares
Today's Volume Vs. Average
25%
Short Selling Harmony Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Harmony Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HRMY Short Interest Over Time

HRMY Days to Cover Over Time

HRMY Percentage of Float Shorted Over Time

Harmony Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20246,060,000 shares $194.71 million -18.7%15.2%8.9 $32.13
10/15/20247,450,000 shares $264.48 million -12.8%24.3%16.9 $35.50
9/30/20248,540,000 shares $341.60 million +1.6%27.8%19.8 $40.00
9/15/20248,410,000 shares $327.23 million -4.0%27.4%21.4 $38.91
8/31/20248,760,000 shares $315.18 million +0.3%28.6%23.5 $35.98
8/15/20248,730,000 shares $307.73 million +3.9%28.5%24 $35.25
7/31/20248,400,000 shares $284.42 million +4.2%27.4%22.4 $33.86
7/15/20248,060,000 shares $274.12 million -3.1%26.3%20 $34.01
6/30/20248,320,000 shares $251.01 million +2.3%27.2%20.4 $30.17
6/15/20248,130,000 shares $236.18 million +17.2%26.5%21.2 $29.05
5/31/20246,940,000 shares $204.04 million -2.1%22.7%17.4 $29.40
5/15/20247,090,000 shares $210.57 million +5.5%23.1%17.1 $29.70
4/30/20246,720,000 shares $207.72 million +4.0%16.1%15.9 $30.91
4/15/20246,460,000 shares $190.70 million +1.7%21.0%17.6 $29.52
3/31/20246,350,000 shares $213.23 million +4.3%20.7%17.5 $33.58
3/15/20246,090,000 shares $194.76 million -3.2%19.8%16.9 $31.98
2/29/20246,290,000 shares $201.91 million -1.9%19.9%15.4 $32.10
2/15/20246,410,000 shares $224.73 million +0.9%20.3%15.1 $35.06
1/31/20246,350,000 shares $200.28 million +1.6%19.5%13.8 $31.54
1/15/20246,250,000 shares $195.75 million +3.5%19.2%10.7 $31.32
12/31/20236,040,000 shares $195.09 million +2.4%18.6%8 $32.30
12/15/20235,900,000 shares $198.65 million -0.8%18.1%7.8 $33.67
11/30/20235,950,000 shares $172.91 million +0.3%17.9%7.6 $29.06
11/15/20235,930,000 shares $149.44 million +11.1%17.9%7.4 $25.20
10/31/20235,340,000 shares $125.70 million -22.6%16.1%6.8 $23.54
10/15/20236,900,000 shares $145.66 million -1.6%20.3%9.4 $21.11
9/30/20237,010,000 shares $229.72 million -4.6%20.6%12.4 $32.77
9/15/20237,350,000 shares $275.77 million -5.0%21.6%13.8 $37.52
8/31/20237,740,000 shares $280.58 million +3.8%22.8%15.7 $36.25
8/15/20237,460,000 shares $245.36 million -2.1%22.0%16.6 $32.89
7/31/20237,620,000 shares $269.52 million -8.5%22.6%16.7 $35.37
7/15/20238,330,000 shares $294.47 million -1.2%24.7%16.7 $35.35
6/30/20238,430,000 shares $296.65 million +2.9%25.0%15.7 $35.19
6/15/20238,190,000 shares $297.05 million +2.1%24.3%9.6 $36.27
5/31/20238,020,000 shares $277.33 million +0.6%23.9%9.2 $34.58
5/15/20237,970,000 shares $291.22 million -2.3%23.8%8.5 $36.54
4/30/20238,160,000 shares $263.08 million +2.1%24.4%8.6 $32.24
4/15/20237,990,000 shares $251.76 million +7.0%24.1%8.9 $31.51
3/31/20237,470,000 shares $243.90 million +19.0%22.6%8 $32.65
3/15/20236,280,000 shares $255.22 million +8.3%19.0%10.6 $40.64
Trump said you could learn something from this man (Ad)

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.
2/28/20235,800,000 shares $255.37 million +8.0%17.5%10.5 $44.03
2/15/20235,370,000 shares $262.16 million +5.5%16.3%10.2 $48.82
1/31/20235,090,000 shares $245.19 million -3.8%15.5%10.7 $48.17
1/15/20235,290,000 shares $250.85 million +21.1%16.2%10.5 $47.42
12/30/20224,370,000 shares $240.79 million +9.3%13.3%8.9 $55.10
12/15/20224,000,000 shares $224.52 million -26.1%12.5%8.8 $56.13
11/30/20225,410,000 shares $323.36 million -4.6%17.0%10.9 $59.77
11/15/20225,670,000 shares $318.09 million -1.7%17.8%11.5 $56.10
10/31/20225,770,000 shares $300.04 million +0.2%18.5%11.3 $52.00
10/15/20225,760,000 shares $294.16 million -5.0%18.5%10.8 $51.07
9/30/20226,060,000 shares $268.40 million +5.6%19.5%11.2 $44.29
9/15/20225,740,000 shares $257.96 million +9.5%18.5%10.1 $44.94
8/31/20225,240,000 shares $230.09 million +2.8%16.9%9.6 $43.91
8/15/20225,100,000 shares $259.59 million +3.0%16.4%9.4 $50.90
7/31/20224,950,000 shares $251.11 million +5.8%16.6%9.2 $50.73
7/15/20224,680,000 shares $251.08 million +6.6%15.7%8.9 $53.65
6/30/20224,390,000 shares $214.10 million +6.3%14.8%8.2 $48.77
6/15/20224,130,000 shares $184.24 million +2.0%14.1%7.9 $44.61
5/31/20224,050,000 shares $176.58 million +1.0%13.8%7.7 $43.60
5/15/20224,010,000 shares $152.30 million +2.6%13.7%7.4 $37.98
4/30/20223,910,000 shares $176.11 million +3.7%14.1%7.6 $45.04
4/15/20223,770,000 shares $194.31 million +3.6%13.7%8.4 $51.54
3/31/20223,640,000 shares $177.09 million +1.4%N/A9.3 $48.65
3/15/20223,590,000 shares $157.31 million +7.2%13.7%9.4 $43.82
2/28/20223,350,000 shares $133.87 million +2.1%12.7%9.3 $39.96
2/15/20223,280,000 shares $130.38 million +10.8%12.6%10.4 $39.75
1/31/20222,960,000 shares $106.15 million -10.0%14.1%9 $35.86
1/15/20223,290,000 shares $120.68 million +10.8%N/A0 $36.68
12/31/20212,970,000 shares $126.64 million -2.9%12.0%6.1 $42.64
12/15/20213,060,000 shares $120.50 million -5.0%12.4%6.4 $39.38
11/30/20213,220,000 shares $109.77 million +22.0%12.9%6.2 $34.09
11/15/20212,640,000 shares $108.27 million +3.5%10.6%5 $41.01
10/29/20212,550,000 shares $105.75 million +94.7%11.6%4.8 $41.47
10/15/20211,310,000 shares $51.61 million -7.1%6.0%2.6 $39.40
9/30/20211,410,000 shares $54.05 million +52.1%6.4%4 $38.33
9/15/2021927,100 shares $33.70 million -4.9%4.1%2.6 $36.35
8/31/2021974,500 shares $33.03 million -10.6%4.3%3.4 $33.89
8/13/20211,090,000 shares $35.04 million +2.8%4.8%3.9 $32.15
7/30/20211,060,000 shares $27.73 million +16.6%4.9%3.7 $26.16
7/15/2021908,800 shares $26.36 million -1.2%4.2%3.4 $29.01
6/30/2021919,700 shares $25.96 million +53.9%4.2%3.7 $28.23
6/15/2021597,700 shares $18.97 million -6.3%2.8%2.9 $31.73
5/28/2021638,000 shares $20.39 million +7.7%2.9%3 $31.96
5/14/2021592,500 shares $15.46 million +20.3%2.9%3.2 $26.10
4/30/2021492,500 shares $14.29 million +61.9%1.7%3.5 $29.01
4/15/2021304,300 shares $8.85 million -54.1%1.1%2.4 $29.08
3/31/2021663,200 shares $21.24 million +7.5%3.2%5.3 $32.03
3/15/2021617,200 shares $18.84 million +5.6%3.0%4.9 $30.52
2/26/2021584,500 shares $21.15 million +23.4%2.9%4.9 $36.18
2/12/2021473,800 shares $18.16 million -3.4%2.3%3.6 $38.33
Trump said you could learn something from this man (Ad)

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.
1/29/2021490,400 shares $17.51 million -27.2%2.4%3.3 $35.71
1/15/2021673,900 shares $26.02 million No Change3.3%4.2 $38.61

HRMY Short Interest - Frequently Asked Questions

What is Harmony Biosciences' current short interest?

Short interest is the volume of Harmony Biosciences shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 6,060,000 shares of HRMY short. 15.15% of Harmony Biosciences' shares are currently sold short. Learn More on Harmony Biosciences' current short interest.

What is a good short interest ratio for Harmony Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HRMY shares currently have a short interest ratio of 9.0. Learn More on Harmony Biosciences's short interest ratio.

Which institutional investors are shorting Harmony Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Harmony Biosciences: Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Harmony Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.15% of Harmony Biosciences' floating shares are currently sold short.

Is Harmony Biosciences' short interest increasing or decreasing?

Harmony Biosciences saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 6,060,000 shares, a decrease of 18.7% from the previous total of 7,450,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Harmony Biosciences' float size?

Harmony Biosciences currently has issued a total of 57,030,000 shares. Some of Harmony Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Harmony Biosciences currently has a public float of 40,010,000 shares.

How does Harmony Biosciences' short interest compare to its competitors?

15.15% of Harmony Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Harmony Biosciences: Xencor, Inc. (7.16%), Taro Pharmaceutical Industries Ltd. (0.85%), OPKO Health, Inc. (30.05%), Prelude Therapeutics Incorporated (13.85%), Axsome Therapeutics, Inc. (15.64%), Corcept Therapeutics Incorporated (20.84%), Legend Biotech Co. (8.70%), Elanco Animal Health Incorporated (2.81%), Blueprint Medicines Co. (6.50%), Lantheus Holdings, Inc. (6.03%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Harmony Biosciences stock?

Short selling HRMY is an investing strategy that aims to generate trading profit from Harmony Biosciences as its price is falling. HRMY shares are trading up $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Harmony Biosciences?

A short squeeze for Harmony Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HRMY, which in turn drives the price of the stock up even further.

How often is Harmony Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HRMY, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:HRMY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners